Search hospitals

>

Georgia

>

Atlanta

Children's Healthcare of Atlanta

Claim this profile

Atlanta, Georgia 30322

Global Leader in Cancer

Global Leader in Brain Tumor

Conducts research for Acute Lymphoblastic Leukemia

Conducts research for Neuroblastoma

Conducts research for Sickle Cell Disease

731 reported clinical trials

60 medical researchers

Photo of Children's Healthcare of Atlanta in AtlantaPhoto of Children's Healthcare of Atlanta in AtlantaPhoto of Children's Healthcare of Atlanta in Atlanta

Summary

Children's Healthcare of Atlanta is a medical facility located in Atlanta, Georgia. This center is recognized for care of Cancer, Brain Tumor, Acute Lymphoblastic Leukemia, Neuroblastoma, Sickle Cell Disease and other specialties. Children's Healthcare of Atlanta is involved with conducting 731 clinical trials across 968 conditions. There are 60 research doctors associated with this hospital, such as William T. Cash, Jason Fangusaro, MD, Edmund Waller, MD, and Tobey MacDonald, MD.

Area of expertise

1

Cancer

Global Leader

Children's Healthcare of Atlanta has run 107 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage I
Stage II
2

Brain Tumor

Global Leader

Children's Healthcare of Atlanta has run 71 trials for Brain Tumor. Some of their research focus areas include:

BRAF positive
Stage IV
NTRK positive

Top PIs

Clinical Trials running at Children's Healthcare of Atlanta

Cancer

Neuroblastoma

Brain Tumor

Acute Lymphoblastic Leukemia

Acute Myeloid Leukemia

Testicular cancer

Diffuse Intrinsic Pontine Glioma

Solid Tumors

Brain Cancer

Leukemia

Image of trial facility.

Gamma Delta T Cell Immunotherapy + Chemoimmunotherapy

for Neuroblastoma

This trial tests a new treatment combining existing cancer drugs with special immune cells and a booster drug in children with aggressive neuroblastoma. The goal is to see if this combination can more effectively fight the cancer.

Recruiting

3 awards

Phase 1

20 criteria

Image of trial facility.

Cabozantinib + 13-cis-Retinoic Acid

for Solid Tumors

This study is being conducted in order to determine the safety, dose-limiting toxicities, and maximum tolerated dose of cabozantinib in combination with 13-cis-retinoic acid in patients with relapsed or refractory solid tumors including tumors of the central nervous system (CNS)

Recruiting

3 awards

Phase 1

6 criteria

Image of trial facility.

Chemotherapy

for Cancer

This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.

Recruiting

2 awards

Phase 3

26 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Children's Healthcare of Atlanta?

Where is Children's Healthcare of Atlanta located?

Who should I call to ask about financial aid or insurance network?

What insurance does Children's Healthcare of Atlanta accept?

What awards or recognition has Children's Healthcare of Atlanta received?